IOBT - IO Biotech Inc
0.2657
-0.014 -5.382%
Share volume: 1,902,638
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$0.28
-0.01
-0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-12-2024 | 05-14-2025 | 11-14-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | |||
| Operating expenses | 20.197 M | 21.533 M | 26.504 M | 22.584 M | 19.355 M | |
| Selling general and admin | 5.886 M | 5.685 M | 6.326 M | 6.209 M | 5.613 M | |
| Research and development | 14.311 M | 15.848 M | 20.178 M | 16.375 M | 13.742 M | |
| Total expenses | 20.197 M | 21.533 M | 26.504 M | 22.584 M | 19.355 M | |
| 6.61% | 23.09% | -14.79% | -14.30% | |||
| Operating income | -20.197 M | -21.533 M | -26.504 M | -22.584 M | -19.355 M | |
| Ebit | -20.659 M | -21.623 M | -24.874 M | -22.689 M | -9.411 M | |
| Pretax income | -19.042 M | -20.312 M | -23.806 M | -22.275 M | -10.042 M | |
| 6.67% | 17.20% | -6.43% | -54.92% | |||
| Income tax | 415.000 K | 374.000 K | 209.000 K | 146.000 K | -1.664 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -19.457 M | -20.686 M | -24.015 M | -22.421 M | -8.378 M | |
| -6.32% | -16.09% | 6.64% | 62.63% |